semaglutide daily Control your hunger without injections 💙 Our once-daily pill helps reduce appetite, boost metabolism, and make weight loss feel simple again. ✨ No needles ✨ Less hunger ✨ Easy routine 50 mg of oral #semaglutide

It also further decreases hunger and craving issues

Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions

If weight loss plateaus for more than three to four weeks at therapeutic dose, reassess dietary intake, exercise programming, sleep quality, and stress management before attributing the plateau to the medication alone

While Wegovy has been FDA-approved for weight loss, users may experience side effects